Advancing the Frontier of
Biologic Therapies
CarePath Biologics is relentlessly committed to maximizing therapeutic potential by harnessing the power of human biology to treat patients suffering from degenerative disease, damaged tissue, injury, and trauma. As one ages, the body’s ability to repair and remodel decreases, causing what is called a broken healing-loop due to a lack of native functional tissue. Employing innovative science, CarePath Biologics is discovering and developing breakthrough therapeutics that hack and optimize the repair process that leads to organized advanced healing with minimal scarring, complications, failure, or re-injury. Our novel approach begins with a platform of naturally advanced human biological material from which we have unraveled the code of complex molecules, isolating and applying them to treat a multitude of conditions across a range of surgical and non-surgical specialties – orthopedics, spine, sports medicine, chronic and complex wounds, plastic surgery, urology, gynecology and general surgery. Targeted therapies under development have the power to help upwards of 50 million patients per year.
CarePath Biologics
Maximum Preservation.
CarePath Biologics BioECM® preservation utilizes the richest natural intact allograft tissue known to exist. With our novel HydraTek® technology, we can maximize preservation and potential through our unique preservation system, to further advance medical treatments. CarePath Biologics® products provide distinct tissue and safety advantages over traditional human allograft or xenograft tissue sources. Placental tissues provide the most abundant source of an extracellular matrix (ECM).
